sterling drug inc said submitted new drug application food and drug administration for permission market oral form corotrope milrinone drug for treating chronic congestive heart failure sterling said application includes series studies 952 patients and results three multicenter studies involving another 571 patients demonstrate efficacy and safety drug alternative digitalis reuter 